L-006235
L-006235 (L-235) is a potent, selective, reversible and orally active inhibitor of cathepsin K, with an IC50 of 5 nM in bone resorption assay. L-006235 shows selectivity for cathepsin K (Ki=0.2 nM) over cathepsin B, cathepsin L, and cathepsin S (Ki=1, 6, and 47 μM, respectively) . L-006235 can reduce collagen degradation and prevent bone loss[1][2].
Product Specifications
CAS Number
294623-49-7
Product Name Alternative
L-235
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Cathepsin
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/l-006235.html
Concentration
10mM
Purity
99.93
Solubility
DMSO : 31.25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1(C(NCC#N)=O)CCCCC1)C2=CC=C(C3=CSC(N4CCN(C)CC4)=N3)C=C2
Molecular Formula
C24H30N6O2S
Molecular Weight
466.60
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cathepsin B; Cathepsin K
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD81 Recombinant Monoclonal Mouse Antibody (2304.81), CF®405M Conjugate - Biotium Choice
Ksp-Cadherin / CDH16 (Renal Cell Marker) (CDH16/2125), CF488A conjugate, 0.1mg/mL
